Biosynthesis, processing and secretion of von Willebrand factor: Biological implications

Best Practice and Research: Clinical Haematology

Volumn 14, Issue 2, 2001, Pages 241-255

  Romani De Wit, Thalia ^a   Van Mourik, Jan A ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Endothelial cells; Factor VIII; von Willebrand factor; von Willebrand factor propeptide; Weibel Palade bodies

Indexed keywords

BLOOD CLOTTING FACTOR 8; CHAPERONE; GENE PRODUCT; GLYCOPROTEIN; PEPTIDE DERIVATIVE; PLASMA PROTEIN; POLYPEPTIDE; VON WILLEBRAND FACTOR;

ARTICLE; BIOSYNTHESIS; BLOOD VESSEL INJURY; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN TRANSPORT; STEM CELL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; WEIBEL PALADE BODY;

EID: 0034924908     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2001.0132     Document Type: Article

References (94)

1. Cell biology of von Willebrand factor
2. Biochemistry and genetics of von Willebrand factor
3. Factor 8 on the vascular intima: Possible importance in haemostasis and thrombosis
4. Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy
5. Synthesis of von Willebrand factor by cultured human endothelial cells
6. Long-term culture of capillary endothelial cells
7. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo
8. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes
9. Biosynthesis of von Willebrand protein by human megakaryocytes
10. Von Willebrand factor
11. Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor
12. Identification of disulphide-bridged substructures within human von Willebrand factor
13. Assembly and routing of von Willebrand factor variants: The requirements for disulphide-linked dimerization reside within the carboxy-terminal 151 amino acids
14. Sulfation of von Willebrand factor
15. Von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies
16. Domains involved in multimer assembly of von Willebrand factor (vWF): Multimerization is independent of dimerization
17. Conformational changes in the D' domain of von Willebrand factor induced by Cys25 and Cys95 mutations lead to factor VIII binding defect and multimeric impairment
18. Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: Requirement of the pro-polypeptide in vWF multimer formation
19. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers
20. Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage
21. A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion
22. Topology and order of formation of interchain disulphide bonds in von Willebrand factor
23. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly
24. Protein disulphide isomerase: Multiple roles in the modification of nascent secretory proteins
25. A pathway for conformational diversity in proteins mediated by intramolecular chaperones
26. Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells
27. Proteolytic processing in the secretory pathway
28. Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes
29. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes
30. PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE
31. Processing of proendothelin-I by human furin convertase
32. Presence of furin mRNA in cultured bovine endothelial cells and possible involvement of furin in the processing of the endothelin precursor
33. Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells
34. Epinephrine induces von Willebrand factor release from cultured endothelial cells: Involvement of cyclic AMP-dependent signalling in exocytosis
35. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture
36. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells
37. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization
38. New cytoplasmic components in arterial endothelia
39. Golgi origin of tubular inclusions in endothelial cells
40. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-I cells
41. Pathways of protein secretion in eukaryotes
42. Induction of specific storage organelles by von Willebrand factor propolypeptide
43. Von Willebrand factor storage and multimerization: 2 independent intracellular processes
44. Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells
45. Small GTP-binding protein RaIA associates with Weibel-Palade bodies in endothelial cells
46. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells
47. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP
48. Inducible secretion of large, biologically potent von Willebrand factor multimers
49. Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of I-deamino-8-D-arginine vasopressin in humans
50. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease
51. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration
52. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome
53. The life cycle of coagulation factor VIII in view of its structure and function
54. A major factor VIII binding domain resides within the aminoterminal 272 amino acid residues of von Willebrand factor
55. Willebrand disease masquerading as haemophilia A
56. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization
57. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor
58. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor
59. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice
60. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor
61. The low-density lipoprotein receptor gene family: Multiple roles in lipid metabolism
62. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism
63. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein
64. Von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation
65. Inhibition of platelet-collagen interaction by propolypeptide of von Willebrand factor
66. A collagen-binding glycoprotein from bovine platelets is identical to propolypeptide of von Willebrand factor
67. Monoclonal antibodies that inhibit binding of propolypeptide of von Willebrand factor to collagen. Localization of epitopes
68. A collagen/gelatin-binding decapeptide derived from bovine propolypeptide of von Willebrand factor
69. Propolypeptide and mature portions of von Willebrand factor of bovine origin recognize different sites on type-I collagen obtained from bovine tendon
70. Immunological detection of propolypeptide of von Willebrand factor on platelet surface
71. Activation of phospholipases in platelets by polyclonal antibodies against a surface membrane protein
72. Propolypeptide of von Willebrand factor serves as a substrate for factor XIIIa and is cross-linked to laminin
73. Identification of factor-XIIIa-reactive glutaminyl residues in the propolypeptide of bovine von Willebrand factor
74. βl-integrin-mediated adhesion of melanoma cells to the propolypeptide of von Willebrand factor
75. Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin
76. Tissue transglutaminase, coagulation factor XIII, and the propolypeptide of von Willebrand factor are all ligands for the integrins α9βI and α4βI
77. The integrin α9βI mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-I
78. Biosynthesis of human von Willebrand factor
79. Small GTP-binding proteins and regulated secretion of von Willebrand factor by endothelial cells
80. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells
81. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells
82. Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex
83. PADGEM (GMPI40) is a component of Weibel-Palade bodies of human endothelial cells
84. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140
85. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies
86. CD63 is a component of Weibel-Palade bodies of human endothelial cells
87. Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin
88. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells
89. Endothelial cell 'memory' of inflammatory stimulation: Human venular endothelial cells store interleukin 8 in Weibel-Palade bodies
90. Localization of α1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells
91. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells
92. An endothelial storage granule for tissue-type plasminogen activator
93. Assembly of multimeric von Willebrand factor directs sorting of P-selectin